Genetic Factors.
Twin studies, adoption studies, and segregation analysis studies all support a genetic cause for Tourette’s disorder. Twin studies indicate that concordance for the disorder in monozygotic twins is significantly greater than that in dizygotic twins. That Tourette’s disorder and chronic motor or vocal tic disorder are likely to occur in the same families lends support to the view that the disorders are part of a genetically determined spectrum. The sons of mothers with Tourette’s disorder seem to be at the highest risk for the disorder. Evidence in some families indicates that Tourette’s disorder is transmitted in an autosomal dominant fashion. Recent studies of a long family pedigree suggest that Tourette’s disorder may be transmitted in a bilinear mode; that is, Tourette’s disorder appears to be inherited through an autosomal pattern in some families, intermediate between dominant and recessive. A recent study of 174 unrelated probands with Tourette’s disorder identified a greater-than-chance occurrence of a rare sequence variant in SLITRK1 believed to be a candidate gene on chromosome 13q31.
A relation is found between Tourette’s disorder and attention-deficit/hyperactivity disorder (ADHD); up to half of all patients with Tourette’s disorder also have ADHD. A relation also appears between Tourette’s disorder and obsessive-compulsive disorder (OCD); up to 40 percent of all individuals with Tourette’s disorder also have OCD. In addition, first-degree relatives of persons with Tourette’s disorder are at high risk for the development of the disorder, of chronic motor or vocal tic disorder, and of OCD. The presence of symptoms of ADHD in more than half of persons with Tourette’s disorder raises questions about a genetic relation between these two disorders.
Neurochemical and Neuroanatomical Factors.
Compelling, but indirect, evidence of dopamine system involvement in tic disorders includes the observations that pharmacological agents that antagonize dopamine (haloperidol [Haldol], pimozide [Orap], and fluphenazine [Prolixin]) suppress tics and that agents that increase central dopaminergic activity (methylphenidate [Ritalin], amphetamines, pemoline [Cylert], and cocaine) tend to exacerbate tics. The relation of tics to neurotransmitter systems is complex and not well understood; for example, in some cases, antipsychotic medications, such as haloperidol, are not effective in reducing tics, and the effect of stimulants on tic disorders reportedly varies. In some cases, Tourette’s disorder has emerged during treatment with antipsychotic medications.
More direct analyses of the neurochemistry of Tourette’s disorder have been possible using brain proton magnetic resonance spectroscopy, a method only recently used to investigate this disorder. A recent investigation examining the cellular neurochemistry of patients with Tourette’s disorder using magnetic resonance spectroscopy of the frontal cortex, caudate nucleus, putamen, and thalamus demonstrated that these patients had a reduced amount of choline and N-acetylaspartate in the left putamen along with reduced levels of bilaterally in the putamen. In the frontal cortex, patients with Tourette’s disorder were found to have lower concentrations of N-acetylaspartate bilaterally, lower levels of creatine on the right side, and reduced myoinositol on the left side. These results imply that deficits in the density of neuronal and nonneuronal cells are present in patients with Tourette’s disorder.
Endogenous opioids may be involved in tic disorders and OCD. Some evidence indicates that pharmacological agents that antagonize
endogenous opiates—for example, naltrexone (ReVia)—reduce tics and attention deficits in patients with Tourette’s disorder. Abnormalities in the noradrenergic system have been implicated in some cases by the reduction of tics with clonidine (Catapres). This adrenergic agonist reduces the release of norepinephrine in the central nervous system and, thus, may reduce activity in the dopaminergic system. Abnormalities in the basal ganglia result in various movement disorders, such as Huntington’s disease, and are implicated as possible sites of disturbance in Tourette’s disorder, OCD, and ADHD.
Immunological Factors and Postinfection.
An autoimmune process that is secondary to streptococcal infections is a potential mechanism for Tourette’s disorder. Such a process could act synergistically with a genetic vulnerability for this disorder. Poststreptococcal syndromes have also been associated with one potential causative factor in the development of OCD in children.